XML 82 R45.htm IDEA: XBRL DOCUMENT
v3.20.1

Organization (Narrative) (Details) - USD ($) | 1 Months Ended | 12 Months Ended
--- | --- | ---
Apr. 30, 2019 | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017
Noncontrolling Interest [Abstract] |  |  |  |
Exercise of options and related tax benefit | $ 1,000,000 |  |  |
Net loss at subsidiary allocated to noncontrolling interests |  | $ 8,752 | $ 75,704 | $ 71,182
Cumberland Emerging Technologies, Inc (CET) |  |  |  |
Noncontrolling Interest [Abstract] |  |  |  |
Noncontrolling interest, ownership percentage by parent |  | 85.00% |  |
HongKong WinHealth Pharma Group Co. Limited |  |  |  |
Noncontrolling Interest [Abstract] |  |  |  |
Investment in CET | 1,000,000.0 |  |  |
Contribution of cash | 300,000 |  |  |
Conversion of intercompany loans payable | 700,000 |  |  |
Gloria Pharmaceuticals |  |  |  |
Noncontrolling Interest [Abstract] |  |  |  |
Exchange for consideration, amount | $ 800,000 |  |  |
Cumberland Emerging Technologies, Inc (CET) | Harbin Gloria Pharmaceuticals Co |  |  |  |
Noncontrolling Interest [Abstract] |  |  |  |
Exercise of options and related tax benefit |  | $ 1,000,000.0 |  |

X
- Definition Contribution of Cash, Additional Shares Purchased + References No definition available. + Details
Name: | cpix_ContributionOfCashAdditionalSharesPurchased
Namespace Prefix: | cpix_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Intercompany Loans Payable, Converted Amount + References No definition available. + Details
Name: | cpix_IntercompanyLoansPayableConvertedAmount
Namespace Prefix: | cpix_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Subsidiary Investment, Payments For Return Of Capital + References No definition available. + Details
Name: | cpix_SubsidiaryInvestmentPaymentsForReturnOfCapital
Namespace Prefix: | cpix_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Subsidiary Investment, Purchase Of Shares + References No definition available. + Details
Name: | cpix_SubsidiaryInvestmentPurchaseOfShares
Namespace Prefix: | cpix_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The parent entity's interest in net assets of the subsidiary, expressed as a percentage. + References No definition available. + Details
Name: | us-gaap_MinorityInterestOwnershipPercentageByParent
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 1B -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669625-108580 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 1A -Subparagraph (a)(2) -URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 1A -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4J -URI http://asc.fasb.org/extlink&oid=84234705&loc=SL4591551-111686 + Details
Name: | us-gaap_NetIncomeLossAttributableToNoncontrollingInterest
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_NoncontrollingInterestAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 1A -Subparagraph (c)(2) -URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 23 -URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569655-111683 + Details
Name: | us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | srt_OwnershipAxis=cpix_CumberlandEmergingTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=cpix_HongKongWinHealthPharmaGroupCoLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=cpix_GloriaPharmaceuticalsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=cpix_CumberlandEmergingTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=cpix_HarbinGloriaPharmaceuticalsCoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |